Add BrightSurf on Google Email

Chances of surviving rare pregnancy-related tumor depends on how long before presentation the related pregnancy occurred

Survival rates for placental-site trophoblastic tumours (PSTTs) vary depending on how long ago the related pregnancy occurred. The study found that patients with stage I disease had a 10-year probability of overall survival of 90%, while those with recurrent disease or disease resistant to treatment had poor survival.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJun 22, 2009

Off-label morning sickness drug deemed safe for fetuses -- Ben-Gurion U. researchers

A large cohort study found that metoclopramide poses no significant risks for fetal development when used to relieve morning sickness nausea, supporting its safe use during pregnancy. The study analyzed data from over 80,000 infants born to mothers who received the medication during the first trimester.

SourceAmerican Associates, Ben-Gurion University of the Negev·JournalNew England Journal of Medicine·DateJun 10, 2009

Intervention reduces delinquent teenage pregancy rates

A study conducted by Oregon State University found that a specialized foster care program reduced teen pregnancy rates among juvenile justice teens. The program, which involved one-on-one care in highly supervised homes, resulted in a 26% pregnancy rate compared to 47% for teens in group care.

SourceOregon State University·JournalJournal of Consulting and Clinical Psychology·DateJun 1, 2009

Women with gestational diabetes during pregnancy have a substantial and persistently elevated risk of type 2 diabetes post birth

A recent study found that women who develop gestational diabetes during pregnancy are seven-and-a-half times more likely to develop type 2 diabetes post-birth. This increased risk remains for several years, emphasizing the need for continued monitoring and intervention. Early identification and treatment of related factors, such as lip...

SourceThe Lancet_DELETED·JournalThe Lancet·DateMay 21, 2009

Pregnant women with mildly abnormal blood sugar levels at higher risk of developing type 2 diabetes

Researchers from Institute for Clinical Evaluative Sciences found that even mild abnormalities in glucose testing during pregnancy increase the risk of developing type 2 diabetes. Women with these mild abnormalities are 2.5 times more likely to develop type 2 diabetes compared to those with normal glucose testing.

SourceInstitute for Clinical Evaluative Sciences·JournalDiabetic Medicine·DateMay 20, 2009

Influenza pandemic planning needed to assure adequate care for pregnant women and newborns

A study highlights the need for hospitals to develop formal plans to address priority treatment for pregnant women and newborns in case of an influenza pandemic. Despite 78% having written plans, concerns remain about resource allocation, vaccination safety, and coordination with public health agencies.

SourceUniversity of Pittsburgh Schools of the Health Sciences·JournalEmerging Health Threats Journal·DateMay 13, 2009

Treatment for extreme nausea, vomiting during pregnancy

A collaborative Canada-France study published in the European Journal of Obstetrics and Gynecology and Reproductive Biology found that metoclopramide worked faster to quell symptoms of nausea and vomiting than droperidol. The treatment protocol improved symptoms more quickly and provided a safer option for pregnant women.

SourceUniversity of Montreal·JournalEuropean Journal of Obstetrics & Gynecology and Reproductive Biology·DateMay 6, 2009

Prenatal molecular diagnosis for tuberous sclerosis complex

Researchers from Boston University School of Medicine have developed a prenatal testing method for identifying tuberous sclerosis complex (TSC) in the womb. The technique, which sequences TSC genes in amniotic fluid cells, has been shown to detect nearly 93% of mutations, offering improved treatment options for affected families.

SourceBoston University·JournalAmerican Journal of Obstetrics and Gynecology·DateMar 2, 2009

Is HIV testing during labor feasible?

Research in Cameroon reveals that 88.3% of women are willing to accept HIV testing during labor, leading to a higher rate of detected infections compared to previously estimated rates. The study recommends an opt-out approach for HIV testing during labor to increase the number of mother-infant pairs receiving appropriate treatment.

SourceBMC (BioMed Central)·JournalBMC Pregnancy and Childbirth·DateFeb 26, 2009

Growing danger from post-birth bleeding

A recent study found that post-partum haemorrhage is a significant threat to new mothers in high-income countries, resulting in severe outcomes including infertility and death. The authors recommend increased access to active management of the third stage of labour to reduce PPH rates.

SourceBMC (BioMed Central)·JournalBMC Pregnancy and Childbirth·DateFeb 24, 2009